Metagenomi, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.650
-0.040 (-2.37%)
Nov 20, 2024, 4:00 PM EST - Market closed
Metagenomi Market Cap
Metagenomi has a market cap or net worth of $61.75 million as of November 21, 2024.
Market Cap
61.75M
Enterprise Value
-166.76M
1-Year Change
n/a
Ranking
Category
Stock Price
$1.65
Market Cap Chart
Since the IPO on February 9, 2024, Metagenomi's market cap has decreased from $562.92M to $61.75M, a decrease of -89.03%. That is a compound annual growth rate of -94.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 63.25M | -88.76% |
| Feb 9, 2024 | 562.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Monogram Technologies | 64.35M |
| Procaps Group | 64.29M |
| Celularity | 63.76M |
| Cryo-Cell International | 62.88M |
| Agenus | 62.64M |
| Aileron Therapeutics | 61.96M |
| Champions Oncology | 60.88M |
| Boundless Bio | 60.32M |